The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
4D MOLECULAR THERAPEUTICS IN COM 35104E100 29,631,296 2,227,917 SH SOLE 2,227,917 0 0
ALTIMMUNE INC COM NEW 02155H200 8,086,400 2,660,000 SH SOLE 2,660,000 0 0
AURA BIOSCIENCES INC COM 05153U107 10,247,665 1,443,333 SH SOLE 1,443,333 0 0
AVALO THERAPEUTICS INC COM NEW 05338F306 16,481,961 891,881 SH SOLE 891,881 0 0
BIOMARIN PHARMACEUTICAL INC COM 09061G101 29,296,640 512,000 SH SOLE 512,000 0 0
CAMP4 THERAPEUTICS CORP COM 13463J101 8,446,935 1,932,937 SH SOLE 1,932,937 0 0
CENTURY THERAPEUTICS INC COM 15673T100 10,130,674 4,134,969 SH SOLE 4,134,969 0 0
CYTOKINETICS INC COM NEW 23282W605 24,542,302 288,089 SH SOLE 288,089 0 0
DESIGN THERAPEUTICS INC COM 25056L103 28,958,550 2,001,282 SH SOLE 2,001,282 0 0
FAETH THERAPEUTICS INC COM NEW 81728A207 12,883,375 515,335 SH SOLE 515,335 0 0
FIRST TRACKS BIOTHERAPEUTICS ORD SHS 337185102 30,461,680 1,514,000 SH SOLE 1,514,000 0 0
FORTE BIOSCIENCES INC COM NEW 34962G208 5,805,097 273,181 SH SOLE 273,181 0 0
IMAGENEBIO INC COM 45175G207 1,663,824 282,004 SH SOLE 282,004 0 0
IMMUNOCORE HLDGS PLC ADS 45258D105 33,757,680 1,063,234 SH SOLE 1,063,234 0 0
INCYTE CORP COM 45337C102 17,570,800 155,000 SH SOLE 155,000 0 0
INHIBIKASE THERAPEUTICS INC COM NEW 45719W205 18,374,176 9,051,318 SH SOLE 9,051,318 0 0
INSMED INC COM PAR $.01 457669307 24,557,891 230,331 SH SOLE 230,331 0 0
INVENTIVA SA ADS 46124U107 10,047,228 2,657,997 SH SOLE 2,657,997 0 0
KAILERA THERAPEUTICS INC COMMON STOCK 482931102 21,694,836 984,786 SH SOLE 984,786 0 0
LB PHARMACEUTICALS INC COM SHS 50180M108 49,429,679 1,523,022 SH SOLE 1,523,022 0 0
MINERVA NEUROSCIENCES INC COM NEW 603380205 7,875,450 1,419,000 SH SOLE 1,419,000 0 0
MIRUM PHARMACEUTICALS INC COM 604749101 26,143,136 223,312 SH SOLE 223,312 0 0
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD 61559X104 14,602,500 750,000 SH SOLE 750,000 0 0
NEUROGENE INC COM 64135M105 22,483,133 714,885 SH SOLE 714,885 0 0
NURIX THERAPEUTICS INC COM 67080M103 38,166,318 1,573,220 SH SOLE 1,573,220 0 0
ONKURE THERAPEUTICS INC COM CL A 68277Q105 6,559,359 1,438,456 SH SOLE 1,438,456 0 0
OPUS GENETICS INC COM 67577R102 11,276,434 2,743,658 SH SOLE 2,743,658 0 0
PROMIS NEUROSCIENCES INC COM SHS 74346M505 7,331,475 557,103 SH SOLE 557,103 0 0
RESEARCH ALLIANCE CORP III ORD SHS CL A G75226103 5,350,000 500,000 SH SOLE 500,000 0 0
REVOLUTION MEDICINES INC COM 76155X100 21,677,660 115,750 SH SOLE 115,750 0 0
SOL-GEL TECHNOLOGIES LTD SHS NEW M8694L137 10,338,452 139,445 SH SOLE 139,445 0 0
SYNDAX PHARMACEUTICALS INC COM 87164F105 24,264,600 1,110,000 SH SOLE 1,110,000 0 0
VTV THERAPEUTICS INC CL A NEW 918385204 3,207,479 85,192 SH SOLE 85,192 0 0
X4 PHARMACEUTICALS INC COM NEW 98420X202 12,008,803 2,571,478 SH SOLE 2,571,478 0 0
XENON PHARMACEUTICALS INC COM 98420N105 26,558,400 440,000 SH SOLE 440,000 0 0